{
    "eid": "2-s2.0-85117383239",
    "title": "Clinical outcomes of an ultrathin-strut sirolimus-eluting stent in all-comers population: Thailand Orsiro registry",
    "cover-date": "2021-12-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Cardiology and Cardiovascular Medicine",
            "@code": "2705",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "All-comer",
        "Registry",
        "Sirolimus",
        "Ultrathin-strut"
    ],
    "authors": [
        "Pannipa Suwannasom",
        "Siriporn Athiksakul",
        "Tasalak Thonghong",
        "Vorarit Lertsuwunseri",
        "Jarkarpun Chaipromprasit",
        "Suphot Srimahachota",
        "Wasan Udayachalerm",
        "Srun Kuanprasert",
        "Wacin Buddhari"
    ],
    "citedby-count": 1,
    "ref-count": 28,
    "ref-list": [
        "2018 ESC/EACTS Guidelines on myocardial revascularization",
        "Report of a European Society of Cardiology-European Association of Percutaneous Cardiovascular Interventions task force on the evaluation of coronary stents in Europe: executive summary",
        "Newer-generation ultrathin strut drug-eluting stents versus older second-generation thicker strut drug-eluting stents for coronary artery disease",
        "Long-term efficacy and safety of newer generation ultrathin strut drug-eluting stents: a systematic review and meta-analysis",
        "Ultrathin-strut biodegradable polymer versus durable polymer drug-eluting stents: a meta-analysis",
        "Safety and efficacy of ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer drug-eluting stents: a meta-analysis of randomized trials",
        "Clinical outcomes of silicon carbide coated stents in patients with coronary artery disease",
        "Ultrathin bioresorbable-polymer sirolimus-eluting stents versus thin durable-polymer everolimus-eluting stents for coronary revascularization: 3-year outcomes from the randomized BIOFLOW V Trial",
        "Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a randomised trial",
        "BIOFLOW-IV, a randomised, intercontinental, multicentre study to assess the safety and effectiveness of the Orsiro sirolimus-eluting stent in the treatment of subjects with de novo coronary artery lesions: primary outcome target vessel failure at 12 months",
        "Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with ST-segment elevation myocardial infarction (BIOSTEMI): a single-blind, prospective, randomised superiority trial",
        "Subgroup analysis comparing ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in acute coronary syndrome patients",
        "The BIOFLOW-III Italian Satellite Registry: 18-month results of the Orsiro stent in an all-comer high-risk population",
        "Safety and performance of the Orsiro Sirolimus-eluting stent in the treatment of all-comers patient population in daily clinical practice",
        "Hard Events AfteR Orsiro Sirolimus-Eluting Stent (HEROES) in STEMI: a multicenter registry",
        "Real-world experience with a novel biodegradable polymer sirolimus-eluting stent: twelve-month results of the BIOFLOW-III registry",
        "Five-year results of the Bioflow-III registry: real-world experience with a biodegradable polymer sirolimus-eluting stent",
        "Clinical Outcomes with Unselected Use of an Ultrathin-Strut Sirolimus-Eluting Stent: A Report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)",
        "The Orsiro Ultrathin, bioresorbable-polymer sirolimus-eluting stent: a review of current evidence",
        "Poly-L-lactic acid: an overview",
        "Third universal definition of myocardial infarction",
        "Thin composite wire strut, durable polymer-coated (Resolute Onyx) versus ultrathin cobalt-chromium strut, bioresorbable polymer-coated (Orsiro) drug-eluting stents in allcomers with coronary artery disease (BIONYX): an international, single-blind, randomised non-inferiority trial",
        "Randomized comparison of a biodegradable polymer ultrathin strut sirolimus-eluting stent with a biodegradable polymer biolimus-eluting stent in patients treated with percutaneous coronary intervention: The SORT OUT VII Trial",
        "Three-year clinical outcome of biodegradable hybrid polymer Orsiro sirolimus-eluting stent and the durable biocompatible polymer Resolute Integrity zotarolimus-eluting stent: A randomized controlled trial",
        "Very thin strut biodegradable polymer everolimus-eluting and sirolimus-eluting stents versus durable polymer zotarolimus-eluting stents in allcomers with coronary artery disease (BIO-RESORT): a three-arm, randomised, non-inferiority trial",
        "Clinical end points in coronary stent trials: a case for standardized definitions",
        "Standardized end point definitions for coronary intervention trials: the academic research consortium-2 consensus document"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Chaing Mai",
            "@id": "60000881",
            "affilname": "Chiang Mai University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60000881",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Biotronik Thailand",
        "King Chulalongkorn Memorial Hospital"
    ]
}